Although the CLEC genes, especially CLEC12A or CLL-1, have been previously linked to drug resistance, and proposed as treatment targets in AML [67], CLEC7A was not yet associated with a drug resistance phenotype. The gene discussed is CLEC7A; the disease is acute myeloid leukemia.